Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-12-18
2007-12-18
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S054000, C536S123000, C536S123100
Reexamination Certificate
active
10569959
ABSTRACT:
An object of the present invention is to provide an option of non-reducing saccharide by providing a novel non-reducing saccharide composed of glucose as constituents and to provide a novel enzyme forming the non-reducing saccharide, a method and process for producing the same, a DNA encoding the enzyme, a recombinant DNA and transformant comprising the DNA, a composition comprising the non-reducing saccharide, and uses thereof. The present invention solves the above object by providing a novel cyclic saccharide having a structure of cyclo{→6)-α-D-glucopyranosyl-(1→4)-α-D-glucopyranosyl-(1→6)-α-D-glucopyranosyl-(1→4)-α-D-glucopyranosyl-(1→6}, cyclic maltosylmaltose, novel cyclic maltosylmaltose-forming enzyme, a method and process for producing the same, a DNA encoding the enzyme, a recombinant DNA and transformant comprising the DNA, a composition comprising the cyclic maltosylmaltose or a saccharide composition comprising the same, and uses thereof.
REFERENCES:
patent: 7-143876 (1995-06-01), None
patent: 7-213283 (1995-08-01), None
patent: WO 01/90338 (2001-11-01), None
patent: WO 02/40659 (2002-05-01), None
patent: WO 02/055708 (2002-07-01), None
Aga et al., Production of cyclictetrasaccharide from starch using a novel enzyme system fromBacillus globisporusC11. J. Biosci. Bioeng., 2002, vol. 94(4): 336-342.
Mukai et al (“Purification, Characterization, and Gene Cloning of a Novel Maltosyltransferase from anArthrobacter globiformisStrain That Produces an Alternating .alpha.-1,4- and .alpha.-1,6-Cyclic Tetrasaccharide from Starch”. Applied and Environmental Microbiology, Feb. 2006, pp. 1065-1071.
MUkai et al (“An enzymatically produced novel cyclic tetrasaccharide, cyclo-{-6)-.alpha.-D- Glcp- (1-4)- .alpha.-D- Glcp- (1-6)-.alpha.-D- Glcp- (1-4)-.alpha.-D-Glcp-(11-}(cyclic maltosyl-(1-6)-maltose), from starch”. Carbohydrate Research 340 (2005) pp. 1469-1474.
Dexter French et al., “Studies on the Schardinger Dextrins. The Preparation and Solubility Characteristics of Alpha, Beta and Gamma Dextrins1”, vol. 71(1), pp. 353-356, Jan. 1949.
Fukuda Shigeharu
Kubota Michio
Miyake Toshio
Mukai Kazuhisa
Nishimoto Tomoyuki
Browdy and Neimark PLLC
Jiang Shaojia Anna
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
White Everett
LandOfFree
Cyclic maltosylmatose does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic maltosylmatose, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic maltosylmatose will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3892542